Since testosterone/AR signaling is reduced during aging [19,29] and its reduction is associated with COVID-19 death incidence in men, testosterone therapy may be useful for boosting TMPRSS2/ACE2 signaling, and thereby reducing COVID-19 death incidence. The gene discussed is TMPRSS2; the disease is COVID-19.